Aveanna Healthcare Holdings Inc. $AVAH Shares Sold by J.H. Whitney Equity Partners VII LLC

J.H. Whitney Equity Partners VII LLC lowered its stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 0.2% during the third quarter, Holdings Channel.com reports. The fund owned 45,840,599 shares of the company’s stock after selling 81,882 shares during the quarter. Aveanna Healthcare comprises 100.0% of J.H. Whitney Equity Partners VII LLC’s investment portfolio, making the stock its biggest position. J.H. Whitney Equity Partners VII LLC owned about 0.22% of Aveanna Healthcare worth $406,606,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. AQR Capital Management LLC grew its position in shares of Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after purchasing an additional 4,602 shares during the period. Goldman Sachs Group Inc. lifted its stake in Aveanna Healthcare by 8.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock valued at $1,842,000 after buying an additional 25,974 shares in the last quarter. Jane Street Group LLC boosted its holdings in Aveanna Healthcare by 522.0% in the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock worth $407,000 after buying an additional 63,010 shares during the last quarter. MQS Management LLC purchased a new stake in Aveanna Healthcare during the 2nd quarter worth approximately $59,000. Finally, Belvedere Trading LLC purchased a new position in shares of Aveanna Healthcare in the second quarter valued at approximately $62,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insiders Place Their Bets

In other Aveanna Healthcare news, CEO Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $7.85, for a total transaction of $230,452.45. Following the completion of the sale, the chief executive officer directly owned 2,394,179 shares in the company, valued at $18,794,305.15. This trade represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total transaction of $143,969.00. Following the completion of the sale, the chief financial officer owned 436,980 shares of the company’s stock, valued at $3,430,293. This trade represents a 4.03% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 259,638 shares of company stock valued at $2,109,595. 7.80% of the stock is owned by company insiders.

Aveanna Healthcare Trading Up 1.3%

AVAH opened at $7.93 on Friday. The stock has a market capitalization of $1.66 billion, a PE ratio of 22.03 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The business’s 50 day moving average price is $8.60 and its 200 day moving average price is $8.34.

Analysts Set New Price Targets

AVAH has been the subject of several research reports. William Blair assumed coverage on Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating for the company. Barclays increased their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research report on Friday, January 16th. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 price objective on shares of Aveanna Healthcare in a research note on Friday, December 5th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.